在心力衰竭患者的心脏再同步治疗后,提高生活质量的预测因素
1Department of Cardiology, University of Health Sciences, Bursa City Hospital, Bursa, Turkey. drdursuntopal@hotmail.com.
概括
心脏再同步治疗 (CRT) 显著改善了心力衰竭患者的生活质量 (QoL). 右心室功能测量,特别是三圆形平面缩外流 (TAPSE) 和RV横向S,预测CRT后的QoL改善.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 生活质量研究 研究 生命质量研究
背景情况:
- 心力衰竭 (HF) 显著影响患者的生活质量 (QoL).
- 心脏再同步疗法 (CRT) 是一些心脏衰竭患者的一种治疗选择.
- 需要进一步阐明CRT后QOL改善的预测因素.
研究的目的:
- 评估CRT对HF患者临床和心声学参数的影响.
- 用MOS 36项简短形式的健康调查 (SF-36) 来评估QOL的变化.
- 确定CRT后QOL改善的预测因素.
主要方法:
- 研究了一组97名接受CRT植入的高压患者.
- 在基线和6个月收集的数据包括人口统计,实验室发现,心声学和SF-36分数.
- 统计分析比较了基线和随访数据,并确定了QOL改善的预测因素.
主要成果:
- 三分之二的患者在6个月后对CRT有良好的反应.
- 67名患者经历了显著的 QoL 改善 (SF-36 评分).
- 较高的基线TAPSE和RV-lateral-S与QOL的改善有关,分别为15.5和9.65的截止值.
结论:
- 三环状平面缩外流 (TAPSE) 和右心室侧侧峰缩速度 (RV-lateral-S) 是CRT后QoL改善的显著预测因素.
- 对右心室功能的术前评估对于优化CRT患者的QoL结果至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Heart Failure III: Clinical Manifestations
24
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
24


